Skip to main content

Advertisement

SpringerLink
Log in

Chemotherapy and Targeted Therapy for Gall Bladder Cancer

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Gall bladder cancer is a common cancer in the Ganges belt of North-eastern India. In view of incidental diagnosis of gall bladder cancer by physicians and surgeons, the treatment is not optimised. Most patients present in advanced stages and surgery remains the only option to cure. This review highlights the current evidence in advances in systemic therapy of gall bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mahantshetty UM, Palled SR, Engineer R, Homkar G, Shrivastava SK, Shukla PJ (2006) Adjuvant radiation therapy in gall bladder cancers: 10 years experience at Tata memorial hospital. J Cancer Res Ther 2(2):52–56

    Article  PubMed  Google Scholar 

  2. Jarnagin WR, Ruo L, Little SA, Klimstra D, D’Angelica M, DeMatteo RP et al (2003) Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 98(8):1689–1700

    Article  PubMed  Google Scholar 

  3. Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H et al (2009) Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg 250(6):950–956

    Article  PubMed  Google Scholar 

  4. Morrow CE, Sutherland DE, Florack G, Eisenberg MM, Grage TB (1983) Primary gallbladder carcinoma: significance of subserosal lesions and results of aggressive surgical treatment and adjuvant chemotherapy. Surgery 94(4):709–714

    CAS  PubMed  Google Scholar 

  5. Oswalt CE, Cruz AB Jr (1977) Effectiveness of chemotherapy in addition to surgery in treating carcinoma of the gallbladder. Rev Surg 34(6):436–438

    CAS  PubMed  Google Scholar 

  6. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H et al (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95(8):1685–1695

    Article  PubMed  Google Scholar 

  7. Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y et al (2008) Gallbladder cancer (GBC): 10-year experience at memorial sloan-kettering cancer centre (MSKCC). J Surg Oncol 98(7):485–489

    Article  CAS  PubMed  Google Scholar 

  8. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273–1281

    Article  CAS  PubMed  Google Scholar 

  9. Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Quebbeman EJ (2002) Improved survival in resected biliary malignancies. Surgery 132(4):555–563, discission 563–564

    Article  PubMed  Google Scholar 

  10. Mojica P, Smith D, Ellenhorn J (2007) Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol 96(1):8–13

    Article  PubMed  Google Scholar 

  11. Kraybill WG, Lee H, Picus J, Ramachandran G, Lopez MJ, Kucik N et al (1994) Multidisciplinary treatment of biliary tract cancers. J Surg Oncol 55(4):239–245

    Article  CAS  PubMed  Google Scholar 

  12. Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH et al (2009) Adjuvant therapy for gallbladder carcinoma: the Mayo clinic experience. Int J Radiat Oncol Biol Phys 75(1):150–155

    Article  CAS  PubMed  Google Scholar 

  13. Todoroki T, Kawamoto T, Takahashi H, Takada Y, Koike N, Otsuka M et al (1999) Treatment of gallbladder cancer by radical resection. Br J Surg 86(5):622–627

    Article  CAS  PubMed  Google Scholar 

  14. Mahe M, Stampfli C, Romestaing P, Salerno N, Gerard JP (1994) Primary carcinoma of the gall-bladder: potential for external radiation therapy. Radiother Oncol J Eur Soc Ther Radiol Oncol 33(3):204–208

    Article  CAS  Google Scholar 

  15. Mehta A, Bahadur AK, Aranya RC, Jain AK (1996) Role of radiation therapy in carcinoma of the gall bladder–a preliminary indian experience. Trop Gastroenterol Off J Dig Dis Found 17(1):22–25

    CAS  Google Scholar 

  16. Nadler LH, McSherry CK (1992) Carcinoma of the gallbladder: review of the literature and report on 56 cases at the Beth Israel medical center. Mt Sinai J Med N Y 59(1):47–52

    CAS  Google Scholar 

  17. Kresl JJ, Schild SE, Henning GT, Gunderson LL, Donohue J, Pitot H et al (2002) Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 52(1):167–175

    Article  PubMed  Google Scholar 

  18. Bosset JF, Mantion G, Gillet M, Pelissier E, Boulenger M, Maingon P (1989) Primary carcinoma of the gallbladder. Adjuvant postoperative external irradiation. Cancer 64(9):1843–1847

    Article  CAS  PubMed  Google Scholar 

  19. Todoroki T, Kawamoto T, Otsuka M, Koike N, Yoshida S, Takada Y et al (1999) Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer. Hepatogastroenterology 46(27):1585–1591

    CAS  PubMed  Google Scholar 

  20. Houry S, Barrier A, Huguier M (2001) Irradiation therapy for gallbladder carcinoma: recent advances. J Hepatobiliary Pancreat Surg 8(6):518–524

    Article  CAS  PubMed  Google Scholar 

  21. Czito BG, Hurwitz HI, Clough RW, Tyler DS, Morse MA, Clary BM et al (2005) Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 62(4):1030–1034

    Article  PubMed  Google Scholar 

  22. Cho SY, Kim SH, Park S-J, Han S-S, Kim Y-K, Lee K-W et al (2010) Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol 102(1):87–93

    Article  PubMed  Google Scholar 

  23. Chao TC, Greager JA (1991) Primary carcinoma of the gallbladder. J Surg Oncol 46(4):215–221

    Article  CAS  PubMed  Google Scholar 

  24. Itoh H, Nishijima K, Kurosaka Y, Takegawa S, Kiriyama M, Dohba S et al (2005) Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder. Dig Dis Sci 50(12):2231–2242

    Article  PubMed  Google Scholar 

  25. Todoroki T, Iwasaki Y, Orii K, Otsuka M, Ohara K, Kawamoto T et al (1991) Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma. World J Surg 15(3):357–366

    Article  CAS  PubMed  Google Scholar 

  26. Busse PM, Cady B, Bothe A Jr, Jenkins R, McDermott WV, Steele G Jr et al (1991) Intraoperative radiation therapy for carcinoma of the gallbladder. World J Surg 15(3):352–356

    Article  CAS  PubMed  Google Scholar 

  27. Lindell G, Holmin T, Ewers SB, Tranberg K-G, Stenram U, Ihse I (2003) Extended operation with or without intraoperative (IORT) and external (EBRT) radiotherapy for gallbladder carcinoma. Hepatogastroenterology 50(50):310–314

    PubMed  Google Scholar 

  28. Horgan AM, Amir E, Walter T, Knox JJ (2012) Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol 30(16):1934–1940

    Article  PubMed  Google Scholar 

  29. Wang SJ, Lemieux A, Kalpathy-Cramer J, Ord CB, Walker GV, Fuller CD et al (2011) Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol Off J Am Soc Clin Oncol 29(35):4627–4632

    Article  Google Scholar 

  30. Sirohi B, Singh A, Seth V. Neoadjuvant therapy in Indian patients with locally advanced gall bladder cancer: Tata Memorial Centre (TMC) experience. J Clin Oncol 32 2014 Suppl 3 Abstr 379 [Internet]. [cited 2014 Jan 18]; Available from: http://gicasym.org/content/122842-143

  31. De Aretxabala X, Roa I, Berrios M, Hepp J, Gallardo J, Cordova A et al (2006) Chemoradiotherapy in gallbladder cancer. J Surg Oncol 93(8):699–704

    Article  PubMed  Google Scholar 

  32. De Aretxabala X, Losada H, Mora J, Roa I, Burgos L, Yáñez E (2004) [Neoadjuvant chemoradiotherapy in gallbladder cancer]. Rev Médica Chile 132(1):51–57

    Google Scholar 

  33. Engineer R, Wadasadawala T, Mehta S, Mahantshetty U, Purandare N, Rangarajan V et al (2011) Chemoradiation for unresectable gall bladder cancer: time to review historic nihilism? J Gastrointest Cancer 42(4):222–227

    Article  PubMed  Google Scholar 

  34. Kumaran V, Gulati S, Paul B, Pande K, Sahni P, Chattopadhyay K (2002) The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol 12(8):1993–1999

    Article  PubMed  Google Scholar 

  35. Saluja SS, Gulati M, Garg PK, Pal H, Pal S, Sahni P (2008) Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 6(8):944–950

    Google Scholar 

  36. Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V et al (2010) Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol Off J Am Soc Clin Oncol 28(30):4581–4586

    Article  CAS  Google Scholar 

  37. Patt YZ, Hassan MM, Aguayo A, Nooka AK, Lozano RD, Curley SA et al (2004) Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer 101(3):578–586

    Article  CAS  PubMed  Google Scholar 

  38. Ducreux M, Rougier P, Fandi A, Clavero-Fabri MC, Villing AL, Fassone F et al (1998) Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol Off J Eur Soc Med Oncol ESMO 9(6):653–656

    Article  CAS  Google Scholar 

  39. Rao S, Cunningham D, Hawkins RE, Hill ME, Smith D, Daniel F et al (2005) Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer. Br J Cancer 92(9):1650–1654

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. Nehls O, Oettle H, Hartmann JT, Hofheinz R-D, Hass HG, Horger MS et al (2008) Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial. Br J Cancer 98(2):309–315

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Riechelmann RP, Townsley CA, Chin SN, Pond GR, Knox JJ (2007) Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. Cancer 110(6):1307–1312

    Article  CAS  PubMed  Google Scholar 

  42. Cho J-Y, Nam J-S, Park M-S, Yu J-S, Paik Y-H, Lee S-J et al (2005) A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma. Yonsei Med J 46(4):526–531

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Valle JW, Furuse J, Jitlal M, Beare S, Mizuno N, Wasan H, et al. Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2013 Dec 18;

  44. André T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D et al (2004) Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol Off J Eur Soc Med Oncol ESMO 15(9):1339–1343

    Article  Google Scholar 

  45. Philip PA, Mahoney MR, Allmer C, Thomas J, Pitot HC, Kim G et al (2006) Phase II study of erlotinib in patients with advanced biliary cancer. J Clin Oncol Off J Am Soc Clin Oncol 24(19):3069–3074

    Article  CAS  Google Scholar 

  46. Lubner SJ, Mahoney MR, Kolesar JL, Loconte NK, Kim GP, Pitot HC et al (2010) Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study. J Clin Oncol Off J Am Soc Clin Oncol 28(21):3491–3497

    Article  CAS  Google Scholar 

  47. NCT00363584. Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer [Internet]. Available from: http://clinicaltrials.gov/ct2/show/NCT00363584?term=BILCAP+trial&rank=1

  48. Ben-David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, Zalupski M et al (2006) External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 66(3):772–779

    Article  PubMed  Google Scholar 

  49. González ME, Giannini OH, González P, Saldaña B (2011) Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 13(7):480–484

    Google Scholar 

  50. De Aretxabala X, Roa I, Burgos L, Cartes R, Silva J, Yañez E et al (1999) Preoperative chemoradiotherapy in the treatment of gallbladder cancer. Am Surg 65(3):241–246

    PubMed  Google Scholar 

  51. Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A et al (2010) Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer 103(4):469–474

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  52. Knox JJ, Hedley D, Oza A, Feld R, Siu LL, Chen E et al (2005) Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol Off J Am Soc Clin Oncol 23(10):2332–2338

    Article  CAS  Google Scholar 

  53. Cho JY, Paik YH, Chang YS, Lee SJ, Lee D-K, Song SY et al (2005) Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer 104(12):2753–2758

    Article  CAS  PubMed  Google Scholar 

  54. Iyer RV, Gibbs J, Kuvshinoff B, Fakih M, Kepner J, Soehnlein N et al (2007) A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study. Ann Surg Oncol 14(11):3202–3209

    Article  PubMed  Google Scholar 

  55. Thongprasert S, Napapan S, Charoentum C, Moonprakan S (2005) Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol Off J Eur Soc Med Oncol ESMO 16(2):279–281

    Article  CAS  Google Scholar 

  56. Meyerhardt JA, Zhu AX, Stuart K, Ryan DP, Blaszkowsky L, Lehman N et al (2008) Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. Dig Dis Sci 53(2):564–570

    Article  CAS  PubMed  Google Scholar 

  57. Kim ST, Park JO, Lee J, Lee KT, Lee JK, Choi S-H et al (2006) A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 106(6):1339–1346

    Article  CAS  PubMed  Google Scholar 

  58. Harder J, Riecken B, Kummer O, Lohrmann C, Otto F, Usadel H et al (2006) Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer. Br J Cancer 95(7):848–852

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Verderame F, Russo A, Di Leo R, Badalamenti G, Santangelo D, Cicero G, et al. Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2006 Jun;17 Suppl 7:vii68–72.

  60. Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S et al (2004) A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer 90(8):1516–1520

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Gallardo JO, Rubio B, Fodor M, Orlandi L, Yáñez M, Gamargo C et al (2001) A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol Off J Eur Soc Med Oncol ESMO 12(10):1403–1406

    Article  CAS  Google Scholar 

  62. Gruenberger B, Schueller J, Heubrandtner U, Wrba F, Tamandl D, Kaczirek K et al (2010) Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study. Lancet Oncol 11(12):1142–1148

    Article  CAS  PubMed  Google Scholar 

  63. Lee J, Park SH, Chang H-M, Kim JS, Choi HJ, Lee MA et al (2012) Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. Lancet Oncol 13(2):181–188

    Article  CAS  PubMed  Google Scholar 

  64. Jensen LH, Lindebjerg J, Ploen J, Hansen TF, Jakobsen A (2012) Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer. Ann Oncol Off J Eur Soc Med Oncol ESMO 23(9):2341–2346

    Article  CAS  Google Scholar 

  65. Sohal DPS, Mykulowycz K, Uehara T, Teitelbaum UR, Damjanov N, Giantonio BJ et al (2013) A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma. Ann Oncol Off J Eur Soc Med Oncol ESMO 24(12):3061–3065

    Article  CAS  Google Scholar 

  66. Zhu AX, Meyerhardt JA, Blaszkowsky LS, Kambadakone AR, Muzikansky A, Zheng H et al (2010) Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol 11(1):48–54

    Article  CAS  PubMed  Google Scholar 

  67. Bekaii-Saab T, Phelps MA, Li X, Saji M, Goff L, Kauh JSW et al (2011) Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers. J Clin Oncol Off J Am Soc Clin Oncol 29(17):2357–2363

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, TMC Tata Memorial Centre, Parel, Mumbai, 400012, India

    Bhawna Sirohi & Ashish Singh

  2. Department of Surgical Oncology, Lilavati Hospital and Research centre, Tata Memorial Centre (TMC), Mumbai, India

    P. Jagannath

  3. Department of GI & HPB Surgery, TMC, Tata Memorial Centre (TMC), Mumbai, India

    Shailesh V. Shrikhande

Authors
  1. Bhawna Sirohi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ashish Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Jagannath
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shailesh V. Shrikhande
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bhawna Sirohi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sirohi, B., Singh, A., Jagannath, P. et al. Chemotherapy and Targeted Therapy for Gall Bladder Cancer. Indian J Surg Oncol 5, 134–141 (2014). https://doi.org/10.1007/s13193-014-0317-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-014-0317-4

Keywords

Search

Navigation